Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Sartorius AG is a leading global supplier of biopharmaceutical manufacturing and laboratory products, primarily serving the life sciences sector. The company operates in key markets including Europe and North America, with a strong portfolio that includes bioreactors, filtration systems, and analytical instruments, leveraging its advanced technologies to maintain a competitive edge.
Sartorius generates revenue through the sale of high-margin bioprocessing equipment and laboratory instruments, benefiting from pricing power due to its established brand and technological leadership. The company also offers services that enhance customer loyalty and recurring revenue.
Demand for biopharmaceutical manufacturing equipment driven by increasing global health needs
Regulatory changes impacting the life sciences sector
Technological advancements in bioprocessing
Mergers and acquisitions activity within the healthcare sector
Technological disruption from emerging biomanufacturing technologies
Regulatory changes that could impact product approvals and market access
Intensifying competition from other bioprocessing equipment manufacturers
Potential market share loss to lower-cost providers
High debt-to-equity ratio (1.58) could limit financial flexibility
Potential liquidity concerns given current ratio of 0.91
moderate - Sartorius is somewhat sensitive to economic cycles as healthcare spending can fluctuate with GDP growth, but the essential nature of biopharmaceuticals provides some insulation.
Rising interest rates can increase financing costs for capital expenditures, impacting Sartorius's ability to invest in growth initiatives and potentially compressing valuation multiples.
minimal - Sartorius operates with a manageable debt level and does not heavily rely on credit markets for its operations.
growth - Sartorius's strong revenue growth and market position in a critical industry attract growth-focused investors.
moderate - historical volatility is in line with industry peers, reflecting both growth potential and market sensitivity.